Audience Q&A and panel discussion.

25 August 2018 (16:18 - 16:28)

Organised by:

Video

Sign in to view the resources

Slides

About the speakers

Professor Wolfgang Koenig

TUM Universitätsklinikum, German Heart Center, Munich (Germany)

Professor Peter Libby

Mass General Brigham, Boston (United States of America)

Professor Jan H Cornel

Radboudumc, Nijmegen (Netherlands (The))

Doctor Paul M Ridker

Brigham and Women's Hospital, Boston (United States of America)

5 More presentations in this session

Presentation thumbnail

Welcome and Introduction - Emerging evidence-based approaches to reduce residual atherosclerotic risk.

Professor W. Koenig (Munich, DE)

Presentation thumbnail

Inflammation in atherosclerosis: time for translation?

Professor P. Libby (Boston, US)

Presentation thumbnail

Identification of residual inflammatory cardiovascular risk.

Professor J. Cornel (Nijmegen, NL)

Presentation thumbnail

Therapeutic strategies for secondary cardiovascular disease prevention.

Doctor P. Ridker (Boston, US)

Presentation thumbnail

Learning points and close - Emerging evidence-based approaches to reduce residual atherosclerotic risk.

Professor W. Koenig (Munich, DE)

Access the full session

Session thumbnail

Emerging evidence-based approaches to reduce residual atherosclerotic risk

The Event

ESC Congress 2018

25 August 2018 16:18 CET

You may be interested in

Congress Presentation

Secondary prevention after one-year of a cardiovascular rehabilitation program: a single-centre analysis

Congress Presentation

Secondary prevention in young patients after acute ST segment elevation myocardial infarction: missing the goals and suffering the penalties

Webinar

Personalised secondary prevention post-ACS: the role of biomarkers

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources